This opportunity is no longer accepting applications.
grant PAR-25-114

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)

This funding opportunity supports research focused on developing new treatment strategies to address serious health impacts following exposure to toxic chemical threats, which might be used in terrorist attacks or be accidentally released. These threats include chemical warfare agents, industrial chemicals, pesticides, and potent synthetic opioids. The research may involve testing new drugs or…

This Notice of Funding Opportunity (NOFO) supports translational exploratory/developmental research that directly advances the discovery of novel treatment strategies, i.e., medical countermeasures (MCMs), that address serious morbidity and mortality after acute exposure to highly toxic chemical…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Neurological Disorders and Stroke

Awards & funding

Total Funding: $275,000
Award Ceiling: $275,000
Award Amount: $275,000

Dates

Opportunity Released: October 24, 2024
Open for Submission: October 24, 2024
Submission Deadline: May 30, 2025
Application Window Closes: May 30, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.